CV Sciences stockholders approve 4x share increase, reverse split up to 1:400; Board reduced to 3

CV Sciences, Inc.

Stockholders elected Dr. Joseph Maroon and Joseph Dowling as directors; 3 prior directors did not stand for re-election.
Authorized shares increased from 200M to 800M; common stock authorized from 190M to 790M.
Reverse stock split approved (1:10 to 1:400), at Board discretion before May 30, 2025.
Board size reduced to 3 members to cut costs, leaving one vacancy.
Ratification of Haskell & White as auditor for FY2022 passed; advisory vote on executive comp approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.